The move also means that 'Avatar 3' will now release on
December 22, 2023, rather than on December 17, 2021, 'Avatar 4' will open on December 19, 2025, instead of December 2024 and 'Avatar 5' will release on December 17, 2027.
Consequently, Teva is licensed to launch a generic version of Victoza as of
December 22, 2023. Under certain circumstances Teva could launch a generic version of Victoza earlier, but not before 22 March 2023, unless the Victoza(R) patents are no longer in force or there is another generic version of Victoza on the market.